Lung Cancer and Personalized Medicine: Current Knowledge and Therapies

Aamir Ahmad
Édition Shirish Gadgeel
Passer aux renseignements sur les produits

Lung Cancer and Personalized Medicine: Current Knowledge and Therapies

Aamir Ahmad
Édition Shirish Gadgeel
Date de sortie :
Prix habituel $160.95
Prix promotionnel $160.95 Prix habituel $0.00
Vente ferme. Aucun retour ni échange.
La livraison de cet article sera effectuée sur rendez-vous par notre transporteur partenaire.
La livraison de cet article sera effectuée sur rendez-vous par notre transporteur partenaire.

Téléchargement numérique

Accès immédiat à votre bibliothèque Kobo

Livrer à

En stock en ligne. Expédition gratuite pour les commandes d’au moins 49 $

Acheter maintenant et ramasser en magasin Bay & Floor

Ramassage gratuit aujourd’hui

Trouver en magasin

En rupture de stock

Trouvé dans : Health, Medical Reference

Obtenez 805 points plum  et profitez d’un rabais additionnel avec plum. En savoir plus

Afficher tous les renseignements

Aperçu

228 PAGESANGLAIS

Info promotionnelle
  • Date de publication : Mar 27, 2019
  • Langue : anglais
  • Nombre de pages : 228
  • Éditeur : Springer Nature
  • ISBN : 9783319795928
  • Dimensions : 6.1" W x 1.0" L x 9.25" H

Aamir Ahmad, PhD, is a Scientist at the Wayne State University School of Medicine, Department of Pathology, and the Karmanos Cancer Institute. He has been a member of leading cancer organizations such as the American Association for Cancer Reseasrch and the Union for International Cancer Control. In addition to serving as a reviewer for a number of peer-reviewed scientific journals, he is currently a Section Editor for the journal PLoS ONE, for which he is responsible for policy drafts and the identification and management of special issues. Dr. Ahmad has published more than 100 scientific papers and has authored numerous book chapters. In addition to the current volume Dr. Ahmad served as the editor of two volumes published by Springer.


Shirish M. Gadgeel, M.D. a Professor in the Department of Oncology at Karmanos Institute/Wayne State University in Detroit. He is the co-leader of the Molecular Therapeutics Program of Karmanos Cancer Institute and the leader of the Multidisciplinary Thoracic Oncology team. Dr. Gadgeel is a member of several professional societies, including the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. He currently serves on the Editorial Board of the journalsCancerandClinical Lung Cancer.Dr. Gadgeel is a Principal Investigator of several trials focused on the treatment of Lung Cancer, and has published more than 80 scientific papers

"The aim of this book is to discuss current knowledge about lung cancer with a specific focus on non-small-cell lung cancer (NSCLC). . The intended audience is established researchers, clinicians, healthcare professionals, and students in the medical and scientific community. . The authors have successfully compiled a well-written, comprehensive, and robust book about NSCLC . ." (Karen L. Reckamp, Doody''s Book Reviews, August, 2016)

Articles récemment consultés